Acute coronary syndrome patients: TiNOX BioActive Stent and Microcirculation

Sponsored by Hexacath

Chairpersons: N.H. Pijls, R. Wiseth

Learning Objectives

  • To better understand in which patients the TiNOX technology is a solid alternative to current DES
  • To share a critical reflection on the latest clinical studies on TiNOX bioactive coated stents in ACS patients
  • To understand the importance of non-DES treatments
  • To learn about the new technology RayFlow (microcirculation) and its potential in ACS and other clinical indications

Presentations available when logged in:

  • Session objectives
  • BASE-ACS five-years
  • Microcirculation: new window of investigation